Related Experiment Video
Updated: Jul 3, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity
Payman Nasr1, Timothy Carbery, James W Geddes
1Department of Biological Sciences, Kent State University, Ashtabula, OH 44004, USA. pnasr@kent.edu
NMDA receptor antagonists show mixed effects on 3-nitropropionic acid (3NP) neurotoxicity. Memantine delayed striatal damage but did not improve motor deficits, while ifenprodil worsened them, cautioning against their use in metabolic neurodegenerative disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Neurodegeneration
Background:
- Excitotoxicity and oxidative stress via N-methyl-D-aspartate (NMDA) receptors are implicated in 3-nitropropionic acid (3NP)-induced striatal degeneration.
- Conflicting evidence exists regarding the role of NMDA receptor antagonists in mitigating 3NP neurotoxicity.
Purpose of the Study:
- To investigate the role of NMDA receptors in 3NP-induced striatal degeneration, protein oxidation, and motor deficits.
- To evaluate the effects of NMDA receptor antagonists memantine and ifenprodil on 3NP neurotoxicity.
Main Methods:
- Systemic administration of 3-nitropropionic acid (3NP) in a neurodegeneration model.
- Administration of NMDA receptor antagonists memantine and ifenprodil.
- Assessment of striatal lesion development, protein oxidation, and motor impairment.
Main Results:
- Memantine delayed striatal lesion and protein oxidation but did not improve 3NP-induced motor deficits.
- Ifenprodil did not affect striatal degeneration or oxidation but exacerbated motor deficits.
- NMDA receptor antagonists exhibit differential and potentially detrimental effects on 3NP neurotoxicity.
Conclusions:
- Caution is advised when using NMDA receptor antagonists as neuroprotective agents in metabolic neurodegenerative conditions.
- The complex role of NMDA receptor modulation in 3NP toxicity warrants further investigation.
- Therapeutic strategies for neurodegeneration should consider the specific mechanisms of receptor involvement.
More Related Videos
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
07:11Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity
Published on: September 19, 2025
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Physical Properties of Amines